Clip: AI-Powered Digital Twins Give Clinical Trials a 75-Year Upgrade
0:21
A new wave of generative AI and digital twin technology could be poised to upend the $100 billion clinical trial industry.
Related Videos
In Monday Conversation
-
Play video FIS Says Risk Negotiation at the Point of Sale Is New Merchant-Issuer Model
FIS Says Risk Negotiation at the Point of Sale Is New Merchant-Issuer Model
Jim Johnson of FIS says the Kipp-powered model flips “declined” debit messages into instant approvals. Don’t miss this conversation.
7:40
-
Play video FIS Says Risk Negotiation at the Point of Sale Is New Merchant-Issuer Model
FIS Says Risk Negotiation at the Point of Sale Is New Merchant-Issuer Model
Jim Johnson of FIS says the Kipp-powered model flips “declined” debit messages into instant approvals. Don’t miss this conversation.
21:05
-
Play video Live | Monday Conversation | Currency.com | Konstantin Anissimov
Live | Monday Conversation | Currency.com | Konstantin Anissimov
23:04
-
Play video Inside the Tariff Turbulence from the Epicenter of American Agriculture
Inside the Tariff Turbulence from the Epicenter of American Agriculture
Agribusiness relies on its ability to adapt. Software provider Bushel CEO Jake Joraanstad says adaptation is happening with digital speed.
23:10
-
Play video AI-Powered Digital Twins Give Clinical Trials a 75-Year Upgrade
AI-Powered Digital Twins Give Clinical Trials a 75-Year Upgrade
A new wave of generative AI and digital twin technology could be poised to upend the $100 billion clinical trial industry.
6:08
-
Play video Expedia's Private-Label Push Turns Loyalty Points Into Economic Leverage
Expedia's Private-Label Push Turns Loyalty Points Into Economic Leverage
Inflation and tariff anxieties aside, business must go on. It's a message that's finding traction at Expedia. It's tapping into consumers' growing appetite for personalized rewards programs, driving double-digit growth in its B2B private-label busine
23:41
